Caption Management’s Alibaba BABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.27M Sell
50,000
-30,000
-38% -$4.51M 0.04% 467
2025
Q4
$11.7M Buy
+80,000
New +$13M 0.08% 294
2025
Q3
Sell
-85,000
Closed -$9.64M 1662
2025
Q2
$9.64M Sell
85,000
-15,000
-15% -$1.78M 0.11% 215
2025
Q1
$13.2M Hold
100,000
0.13% 145
2024
Q4
$8.48M Buy
+100,000
New +$9.45M 0.08% 236
2023
Q4
Sell
-23,900
Closed -$2.07M 1336
2023
Q3
$2.07M Hold
23,900
0.03% 567
2023
Q2
$1.99M Buy
+23,900
New +$2.09M 0.04% 495
2022
Q3
Sell
-25,000
Closed -$2.84M 1492
2022
Q2
$2.84M Sell
25,000
-19,900
-44% -$1.95M 0.04% 560
2022
Q1
$4.89M Buy
44,900
+4,900
+12% +$565K 0.06% 432
2021
Q4
$4.75M Hold
40,000
0.05% 474
2021
Q3
$5.92M Buy
+40,000
New +$7.28M 0.07% 379
2020
Q4
Sell
-38,000
Closed -$11.2M 968
2020
Q3
$11.2M Hold
38,000
0.26% 85
2020
Q2
$8.2M Buy
+38,000
New +$7.91M 0.27% 89

Other funds holding BABA

Caption Management's BABA Position: Q1 2026 in Review

Caption Management opened a new position in Alibaba (BABA) in Q1 2026: 24,500 shares worth $3.07M. The stake represents 0.02% of the portfolio and ranks #685 among its holdings. This is a return to the name: Caption Management previously reported a position in BABA as recently as Q3 2025.

Caption Management first reported a position in BABA in Q4 2018 and has held it in 15 quarters since. The position peaked at $7.33M in Q4 2021. 1,343 funds tracked by Wall St. Rank hold BABA as of Q1 2026.

  • Caption Management held 24,500 shares of Alibaba worth $3.07M as of Q1 2026.
  • Alibaba was a new Caption Management position in Q1 2026.
  • Alibaba made up 0.02% of Caption Management's portfolio in Q1 2026, its #685 holding.
  • Caption Management first reported a position in Alibaba in Q4 2018 and has held it in 15 quarters since.
  • Caption Management's Alibaba position peaked at $7.33M in Q4 2021.
  • 1,343 funds tracked by Wall St. Rank held Alibaba as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.